Case Report

Accepted on 06 Nov 2024

Case report: Identification of a novel TOR1AIP2::ETV6 transcript with FLT3-ITD mutation in acute myeloid leukemia progressed from myelodysplastic symdrome

in Hematologic Malignancies

Jun Xia
Guanqun Yang
Qingling Yu
Ruiyi Zhang
Man Wang
Hongli Sun
Heng Chen
Lingling Wang
Ping Chen
Kai-Li Gu

Frontiers in Oncology

doi 10.3389/fonc.2024.1466590

Clinical Trial

Accepted on 05 Nov 2024

A sixteen-week progressive exercise training intervention in treatment-naïve chronic lymphocytic leukaemia: a randomised-controlled pilot study

in Hematologic Malignancies

Frankie Fantom Brown
Rebecca Oliver
Rachel Eddy
Adam J Causer
Annabelle Emery
Harrison D Collier-Bain
David Dutton
Josephine Crowe
Daniel Augustine
John Graby

Frontiers in Oncology

doi 10.3389/fonc.2024.1472551

Mini Review

Published on 04 Nov 2024

Review of BCL2 inhibitors for the treatment of Waldenström’s macroglobulinaemia and non-IgM lymphoplasmacytic lymphoma

in Hematologic Malignancies

Oliver Tomkins

Frontiers in Oncology

doi 10.3389/fonc.2024.1490202

550 views

Original Research

Published on 31 Oct 2024

End-of-life management of multiple myeloma patients in the era of CD38 and immunotherapy

in Hematologic Malignancies

Pierre Sesques
Lionel Karlin
Emmanuel Massy
Alizée Maarek
Guillaume Aussedat
Anne Lazareth
Camille Golfier
Fadhela Bouafia-Sauvy
Helene Lequeu
Dana Ghergus

Frontiers in Oncology

doi 10.3389/fonc.2024.1436587

446 views

Case Report

Published on 31 Oct 2024

TIPIC syndrome in a patient following sorafenib treatment for acute myeloid leukemia: a rare case report

in Hematologic Malignancies

Chang Chen
Jinman Zhong
Wanzhen Hu
Jiewen Tan

Frontiers in Oncology

doi 10.3389/fonc.2024.1484256

443 views

Review

Published on 31 Oct 2024

Immunophenotyping myelodysplastic neoplasms: the role of flow cytometry in the molecular classification era

in Hematologic Malignancies

Evgenia Verigou
Theodora Chatzilygeroudi
Vasileios Lazaris
Anne-Lise de Lastic
Argiris Symeonidis

Frontiers in Oncology

doi 10.3389/fonc.2024.1447001

444 views

Original Research

Published on 31 Oct 2024

The identification and correction of pseudohypercalcemia

in Hematologic Malignancies

Tongyong Yu
Xiaozhe Li
Beihui Huang
Jingli Gu
Junru Liu
Meilan Chen
Juan Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1441851

374 views

Brief Research Report

Published on 24 Oct 2024

Complex karyotypes in hematologic disorders: a 12-year single-center study from Lebanon

in Hematologic Malignancies

Souraya Rammal
Farid Abou Abdallah
Charbel Attieh
Zeinab El Mounajjed
Warde Semaan
Alain Chebly

Frontiers in Oncology

doi 10.3389/fonc.2024.1480793

322 views

Case Report

Accepted on 22 Oct 2024

Paraganglioma Masquerading as Angiosarcoma: Diagnostic Dilemma in Vascular Tumors

in Hematologic Malignancies

Lenny Suryani Safri
Ahilan Raj Rajoo
Saravanan Kannairan
Hisham Arshad Habeebullah Khan
Mohamad Azim Md Idris
Geok Chin Tan
Kishen Raj Chandra Sakaran

Frontiers in Oncology

doi 10.3389/fonc.2024.1462956

Review

Published on 22 Oct 2024

Cellular therapy in older adults with relapsed/refractory diffuse large B-cell lymphoma

in Hematologic Malignancies

Naseem Esteghamat
Aaron Tsumura
Gabriel Marquez-Arreguin
Joseph Tuscano

Frontiers in Oncology

doi 10.3389/fonc.2024.1481950

735 views

Mini Review

Published on 22 Oct 2024

The evolving role of checkpoint inhibitors in the treatment of Hodgkin lymphoma

in Hematologic Malignancies

Amanda F. Cashen

Frontiers in Oncology

doi 10.3389/fonc.2024.1392653

478 views

Review

Accepted on 21 Oct 2024

Recommendations for the Effective Use of T-Cell-Redirecting Therapies: A Canadian Consensus Statement

in Hematologic Malignancies

Guido Lancman
Kevin Song
Darrell White
Tina Crosbie
Ismail Sharif
Marianne Emond
Muhammad Saleem Raza
Martine Elias
Rayan Kaedbey
Michael P Chu

Frontiers in Oncology

doi 10.3389/fonc.2024.1446995

101 views

Original Research

Accepted on 21 Oct 2024

Bone marrow involvement in solid tumors -a retrospective observational study

in Hematologic Malignancies

Bicheng Zhang
Lan Jin
Dang Wu
Jing Xu
Siyu Guo
Jingjing Li
Ting Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1434709

Original Research

Published on 17 Oct 2024

Effectiveness of high efficiency particulate (HEPA) air condition combined with the antifungal prophylaxis on incidence, morbidity and mortality of invasive fungal infections in patients with acute myeloid leukemia: a retrospective single-center study

in Hematologic Malignancies

Linda Preyer
Eik Vettorazzi
Walter Fiedler
Holger Rohde
Jannik Stemler
Saskia Gönner
Carsten Bokemeyer
Cyrus Khandanpour
Friederike Wortmann

Frontiers in Oncology

doi 10.3389/fonc.2024.1429221

625 views

Editorial

Published on 17 Oct 2024

Editorial: Novelties in acute myeloid leukemia: from biology to clinical applications

in Hematologic Malignancies

Luca Vincenzo Cappelli
Nico Gagelmann
Hassan Awada
Carmelo Gurnari

Frontiers in Oncology

doi 10.3389/fonc.2024.1499272

442 views

Original Research

Published on 17 Oct 2024

COVID-19 in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS): a propensity matched analysis (2020-2021)

in Hematologic Malignancies

Barath Prashanth Sivasubramanian
Shashvat Joshi
Diviya Bharathi Ravikumar
Madhumithaa Jagannathan
Sonia Babu
Shanthi Reddy Sripathi
Avinash Javvaji
Priyanshu Jain
Dinesh Kumar Shanmugam
Bharath Duraisamy Swami Kannan

Frontiers in Oncology

doi 10.3389/fonc.2024.1446482

769 views

Navigation group

Articles

Case report: Identification of a novel TOR1AIP2::ETV6 transcript with FLT3-ITD mutation in acute myeloid leukemia progressed from myelodysplastic symdrome

A sixteen-week progressive exercise training intervention in treatment-naïve chronic lymphocytic leukaemia: a randomised-controlled pilot study

Review of BCL2 inhibitors for the treatment of Waldenström’s macroglobulinaemia and non-IgM lymphoplasmacytic lymphoma

End-of-life management of multiple myeloma patients in the era of CD38 and immunotherapy

TIPIC syndrome in a patient following sorafenib treatment for acute myeloid leukemia: a rare case report

Immunophenotyping myelodysplastic neoplasms: the role of flow cytometry in the molecular classification era

The identification and correction of pseudohypercalcemia

Complex karyotypes in hematologic disorders: a 12-year single-center study from Lebanon

Paraganglioma Masquerading as Angiosarcoma: Diagnostic Dilemma in Vascular Tumors

Cellular therapy in older adults with relapsed/refractory diffuse large B-cell lymphoma

The evolving role of checkpoint inhibitors in the treatment of Hodgkin lymphoma

Recommendations for the Effective Use of T-Cell-Redirecting Therapies: A Canadian Consensus Statement

Bone marrow involvement in solid tumors -a retrospective observational study

Effectiveness of high efficiency particulate (HEPA) air condition combined with the antifungal prophylaxis on incidence, morbidity and mortality of invasive fungal infections in patients with acute myeloid leukemia: a retrospective single-center study

Editorial: Novelties in acute myeloid leukemia: from biology to clinical applications

COVID-19 in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS): a propensity matched analysis (2020-2021)